The new rule is intended to protect consumers from asbestos exposure in cosmetic products.
The U.S. Food and Drug Administration (FDA) recently proposed a rule under the Modernization of Cosmetics Regulation Act of 2022 to enhance consumer safety by mandating standardized testing for asbestos in talc-based cosmetic products, addressing concerns about potential contamination in these items. If implemented, the rule will require manufacturers to use specific testing methods, including Polarized Light Microscopy (PLM) and Transmission Electron Microscopy (TEM), to detect asbestos.
Manufacturers may alternately rely on a certified analysis from their talc supplier. The rule also mandates recordkeeping to ensure compliance. Cosmetics containing asbestos or using contaminated talc would be classified as adulterated under the Federal Food, Drug, and Cosmetic Act, making their sale prohibited.
FDA’s Office of Cosmetics and Colors Director Linda Katz stated, “We believe that the proposed testing techniques are appropriate methods to detect asbestos to help ensure the safety of talc-containing cosmetic products.”
Asbestos, a known carcinogen, can naturally occur alongside talc in the mining process, posing potential health risks if undetected. A 90-day comment period is currently open for public feedback, after which the FDA will finalize the rule.
As the Lord Leads, Pray with Us…
- For FDA officials as they seek to ensure asbestos does not contaminate cosmetic products.
- For wisdom for incoming members of President Trump’s administration as they assess the current agency policies and priorities.
Sources: Food and Drug Administration